SCHEMBL25966083

SCHEMBL25966083

C[C@H]1[C@@H](F)[C@H](C)O[C@@H]1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12899516 1.00 — —
SCHEMBL13941424 1.00 — —
SCHEMBL13941423 0.81 — —
SCHEMBL15962116 0.79 OGA (0.41) —
SCHEMBL21738820 0.79 OGA (0.41) —
SCHEMBL12899657 0.79 OGA (0.41) —
SCHEMBL12150224 0.79 OGA (0.41) —
SCHEMBL14732693 0.79 OGA (0.41) —
SCHEMBL16708418 0.79 OGA (0.41) —
SCHEMBL7603749 0.79 OGA (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242569-A1 PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS THE SCRIPPS RESEARCH INSTITUTE 2023-08-03 — — US disclosed
US-20230203078-A1 SYNTHESIS OF 3'N NUCLEOSIDES THROUGH OXIME INTERMEDIATES AND RELATED COMPOUNDS Janssen Biopharma, Inc. 2023-06-29 — — US disclosed
Send feedback